Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lippman

Showing results (351-360 of 551) with videos related to

Pageof 56
Sort By:
Annals of Surgical Oncology|April 4, 1998
Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancerD N Danforth, J Zujewski, J O'Shaughnessy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2003
An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasiaCharles M Rudin, Ezra E W Cohen, Vassiliki A Papadimitrakopoulou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Increased epidermal growth factor receptor expression in metaplastic bronchial epitheliumJ M Kurie, H J Shin, J S Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakiaPierre Saintigny, Adel K El-Naggar, Vali Papadimitrakopoulou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2000
Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamideE Singletary, R Lieberman, N Atkinson, et al.
Oncogene|July 4, 2012
Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5T M Ward, E Iorns, X Liu, et al.
Cancer|March 13, 2010
Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancerWilliam N William, Merrill S Kies, Frank V Fossella, et al.
Journal of the National Cancer Institute|December 12, 2024
Optimizing public private partnerships to support clinical cancer researchRoy S Herbst, Gideon Blumenthal, Samir N Khleif, et al.
Archives of Otolaryngology--Head & Neck Surgery|October 16, 1999
Biochemoprevention for dysplastic lesions of the upper aerodigestive tractV A Papadimitrakopoulou, G L Clayman, D M Shin, et al.
Cancer|September 1, 1991
Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancerJ S Lee, H I Libshitz, F V Fossella, et al.
Pageof 56

Showing results (351-360 of 551) with videos related to

Sort By:
Pageof 56
Annals of Surgical Oncology|April 4, 1998
Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancerD N Danforth, J Zujewski, J O'Shaughnessy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2003
An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasiaCharles M Rudin, Ezra E W Cohen, Vassiliki A Papadimitrakopoulou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Increased epidermal growth factor receptor expression in metaplastic bronchial epitheliumJ M Kurie, H J Shin, J S Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakiaPierre Saintigny, Adel K El-Naggar, Vali Papadimitrakopoulou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2000
Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamideE Singletary, R Lieberman, N Atkinson, et al.
Oncogene|July 4, 2012
Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5T M Ward, E Iorns, X Liu, et al.
Cancer|March 13, 2010
Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancerWilliam N William, Merrill S Kies, Frank V Fossella, et al.
Journal of the National Cancer Institute|December 12, 2024
Optimizing public private partnerships to support clinical cancer researchRoy S Herbst, Gideon Blumenthal, Samir N Khleif, et al.
Archives of Otolaryngology--Head & Neck Surgery|October 16, 1999
Biochemoprevention for dysplastic lesions of the upper aerodigestive tractV A Papadimitrakopoulou, G L Clayman, D M Shin, et al.
Cancer|September 1, 1991
Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancerJ S Lee, H I Libshitz, F V Fossella, et al.
Pageof 56